Who You Gonna Call For US Oral Contraceptive Switch? Former FDA Official Heads Perrigo Americas
Jim Dillard, chief scientific officer for Perrigo since 2019, moves to head the North American business with research and development experience as well as a regulatory background from his work at the FDA.
You may also be interested in...
NBA star Antetokounmpo invests in Flexpower; Perrigo changes Americas helm; Bündchen models healthy lifestyle for Gaia; Vit-Best appoints growth chief; Olympian Jennings works with Protein Puck; and more.
Democrat majority at FTC with Bedoya confirmation; Ives leads Perrigos science office; ACI appoints legal affairs director; Biomega promotes Norway factory manager; first leader for BBB National Programs’ outreach center; Embion adds commercial VP; and Clasado adds supply chain, corporate marketing heads.
Nasonex 24HR Allergy also will be first OTC mometasone furoate product available in US. It will compete in OTC intranasal corticosteroids category already led by other brands switched from Rx to nonprescription over past eight years.